Header Logo

John Stock

Concepts (80)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Raloxifene Hydrochloride
12
2013
17
1.740
 Why?
Osteoporosis, Postmenopausal
12
2013
48
1.510
 Why?
Bone Density Conservation Agents
6
2013
45
1.010
 Why?
Selective Estrogen Receptor Modulators
8
2010
15
0.770
 Why?
Fractures, Bone
7
2010
136
0.770
 Why?
Alendronate
5
2013
14
0.730
 Why?
Spinal Fractures
5
2008
36
0.600
 Why?
Bone Density
8
2013
130
0.430
 Why?
Osteoporosis
3
2008
104
0.340
 Why?
Cardiovascular Diseases
3
2008
791
0.240
 Why?
Breast Neoplasms
5
2013
1123
0.220
 Why?
Double-Blind Method
5
2008
715
0.190
 Why?
Estrogen Replacement Therapy
3
2006
78
0.170
 Why?
Femur Neck
3
2005
11
0.130
 Why?
Diphosphonates
3
2010
32
0.120
 Why?
Middle Aged
10
2013
16449
0.110
 Why?
Aged
10
2013
13510
0.110
 Why?
Absorptiometry, Photon
2
2005
74
0.100
 Why?
Female
14
2013
30925
0.100
 Why?
Osteoporotic Fractures
1
2013
29
0.100
 Why?
Treatment Outcome
5
2010
5334
0.100
 Why?
Thiophenes
1
2010
29
0.090
 Why?
Risk
3
2008
368
0.080
 Why?
Piperidines
1
2010
55
0.080
 Why?
Humans
16
2013
59737
0.080
 Why?
Mortality
1
2010
156
0.080
 Why?
Lumbar Vertebrae
3
2005
138
0.080
 Why?
Postmenopause
4
2010
225
0.070
 Why?
Safety
1
2006
141
0.060
 Why?
Calcitonin
2
2004
17
0.060
 Why?
Venous Thrombosis
1
2006
111
0.060
 Why?
Clinical Trials as Topic
1
2008
440
0.060
 Why?
Risk Reduction Behavior
1
2005
121
0.060
 Why?
Randomized Controlled Trials as Topic
3
2004
679
0.060
 Why?
Decision Support Techniques
1
2006
180
0.060
 Why?
Vitamin D
2
2004
134
0.060
 Why?
Bone and Bones
1
2005
136
0.060
 Why?
Cerebrovascular Disorders
1
2004
75
0.050
 Why?
Follow-Up Studies
2
2010
2354
0.050
 Why?
Hip Fractures
1
2004
63
0.050
 Why?
Calcium
2
2004
557
0.050
 Why?
Estrogen Receptor Modulators
1
2002
7
0.050
 Why?
Medical Records
1
2002
133
0.050
 Why?
Logistic Models
1
2004
1240
0.040
 Why?
Aged, 80 and over
2
2010
5147
0.040
 Why?
Health Care Surveys
1
2002
279
0.040
 Why?
Research Design
1
2002
556
0.040
 Why?
Placebos
2
2010
68
0.040
 Why?
Incidence
2
2008
1245
0.030
 Why?
Women's Health
1
2013
361
0.020
 Why?
Bone Resorption
1
2010
41
0.020
 Why?
Comorbidity
1
2013
1083
0.020
 Why?
Adult
1
2004
15771
0.020
 Why?
Cohort Studies
1
2013
2387
0.020
 Why?
Coronary Disease
1
2008
246
0.020
 Why?
Time Factors
2
2005
3629
0.020
 Why?
United States
2
2013
7448
0.020
 Why?
Femoral Neck Fractures
1
2005
8
0.020
 Why?
Poisson Distribution
1
2005
53
0.020
 Why?
Bone Remodeling
1
2005
25
0.010
 Why?
Fracture Healing
1
2005
24
0.010
 Why?
Cost-Benefit Analysis
1
2006
299
0.010
 Why?
Multicenter Studies as Topic
1
2004
130
0.010
 Why?
Age Distribution
1
2004
251
0.010
 Why?
Hormones
1
2004
60
0.010
 Why?
Proportional Hazards Models
1
2005
674
0.010
 Why?
Risk Factors
2
2004
5011
0.010
 Why?
Population Surveillance
1
2004
197
0.010
 Why?
Estrogens
1
2004
110
0.010
 Why?
Global Health
1
2004
168
0.010
 Why?
Disease Notification
1
2002
5
0.010
 Why?
Patient Selection
1
2004
467
0.010
 Why?
Retrospective Studies
1
2013
6153
0.010
 Why?
Reference Values
1
2002
330
0.010
 Why?
Mass Screening
1
2006
651
0.010
 Why?
Guidelines as Topic
1
2002
154
0.010
 Why?
Prevalence
1
2004
1259
0.010
 Why?
Biomarkers
1
2004
1315
0.010
 Why?
Prospective Studies
1
2004
3090
0.010
 Why?
Surveys and Questionnaires
1
2002
2520
0.010
 Why?
Stock's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (80)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_